Basel Medical Group Ltd Ordinary Shares (BMGL) — Cash Flow Reinvestment Rate
Basel Medical Group Ltd Ordinary Shares (BMGL) has a Cash Flow Reinvestment Rate of 0.01x as of June 2024, reinvesting $15.84K (capex $7.92K plus investments $-7.92K) from operating cash flow of $2.51 Million. Explore Basel Medical Group Ltd Ordinary Shares capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Basel Medical Group Ltd Ordinary Shares Cash Flow Reinvestment Rate (2022–2024)
Historical reinvestment intensity for Basel Medical Group Ltd Ordinary Shares across 3 annual periods. Also explore BMGL current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Basel Medical Group Ltd Ordinary Shares (2022–2024)
Year-by-year capital reinvestment analysis for Basel Medical Group Ltd Ordinary Shares. For live market cap and broader valuation context, see BMGL market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.01x | $15.84K | $2.51 Million | $7.92K | ▲ +33.2% |
| 2023 | 0.00x | $12.32K | $2.60 Million | $6.16K | ▼ -92.5% |
| 2022 | 0.06x | $176.99K | $2.79 Million | $88.50K | — |